Searchable abstracts of presentations at key conferences on calcified tissues

ba0002p31 | (1) | ICCBH2013

Craniofacial consequences of high dose zoledronic acid injections in onco-pediatric patients

Lezot Frederic , Chesneau Julie , Battaglia Severine , Brion Regis , Farges Jean-Christophe , Heymann Dominique , Redini Francoise

Background: High doses of zoledronic acid (ZOL), one of the most potent inhibitors of bone resorption; is currently evaluated in a phase III clinical trial in Europe for the treatment of malignant pediatric primary bone tumors. The impact of such an intensive treatment on the craniofacial skeleton is a critical question in the context of patients with actively growing skeleton; in particular in the light of our previous studies evidencing that endochondral bone formation was t...

ba0002p125 | (1) | ICCBH2013

Growth plate modifications in lysophosphatidic acid LPA1 receptor-invalidated mice

Gennero Isabelle , Laurencin-Dalicieux Sara , Conte-Auriol Francoise , Briand-Mesange Fabienne , Chun Jerold , Salles Jean-Pierre

Objectives: Lysophosphatidic acid (LPA) is a potent lipid growth factor which possess several G protein-coupled receptors LPA1-6. We have recently demonstrated that LPA1 receptor-invalidated mice display abnormal bone development and osteoporosis, suggesting abnormal endochondral ossification. We have here further studied the growth plates of LPA1 receptor-invalidated mice.Methods: We performed a microscopic and immuno-histochemistry analysis of the femo...

ba0002p131 | (1) | ICCBH2013

Ghrelin differentiates human osteoblasts via GHS-R1a receptor

Gennero Isabelle , Barre Ronan , Conte-Auriol Francoise , Beton Nicolas , Salles Jean Pierre

Objectives: Ghrelin is a peptide hormone secreted in the stomach, which stimulates GH release and food intake. It is also known to have an effect on bone metabolism. The ghrelin specific receptor, GHS-R1a, belongs to the G protein-coupled receptors (GPCRs). Its downstream pathway in osteoblasts remains unclear. We attempted to clarify the way by which ghrelin acts on osteoblast differentiation.Methods: We studied two human osteosarcoma cell lines, MG63 a...

ba0003pp93 | Cancer and bone: basic, translational and clinical | ECTS2014

Inhibition of TGF-β signaling pathway blocks the development of osteosarcoma lung metastases

Lamora Audrey , Talbot Julie , Bougras Gwenola , Deley Marie Cecile Le , Heymann Dominique , Redini Francoise , Verrecchia Franck

Osteosarcoma is the main malignant primary bone tumor in children and adolescents for whom the prognosis remains poor, especially when metastases are present at diagnosis (survival rate drops to 20% when lung metastases were detected). Because TGF-β has been shown to promote metastases in many solid tumors, we investigated the effects of inhibition of the TGF-β/Smad cascade on osteosarcoma behavior. To this end, two independent procedures, a pharmacological approach ...

ba0006oc19 | (1) | ICCBH2017

Mesenchymal stromal stem cells in pediatric orthopedic oncology, focus on osteosarcoma

Trichet Valerie , Nail Louis-Romee Le , Guiho Romain , Layrolle Pierre , Redini Francoise

Introduction: Conventional therapy of osteosarcoma, a primary malignant bone tumor, includes surgical excision with wide resection, which leads to physical and aesthetic defects. Allografts for reconstruction of bone and joints and adipose tissue autologous grafts for soft tissue defects can be supplemented with mesenchymal stromal/stem cells (MSCs). Additionally MSCs may be used in tumor-targeted cell therapy. However MSCs may have adverse effects on osteosarcoma development,...

ba0007is12 | (1) | ICCBH2019

Orthopaedic management of osteogenesis imperfecta in the bisphosphonate era

Fassier Francois

I. HistoryII. How the bisphosphonates changed the management plan?In babies No need to rod non walking childrenIn toddlers More Upper extremity surgeriesLong-term problems: Risk of delayed non-union:Several measures were introduced to limit the risk (no Bisphosphonates 48 hours pre-op, and 4 months post-op) as well as technical ad...

ba0001pp142 | Cancer and bone: basic, translational and clinical | ECTS2013

Over-expression of Smad7 in osteosarcoma cells inhibits primary tumor growth, the associated bone osteolysis and the development of lung metastasis in murine xenograft model

Lamora Audrey , Talbot Julie , Gobin Berengere , Leduc Marion , Taurelle Julien , Brion Regis , Heymann Dominique , Redini Francoise , Verrecchia Franck

Osteosarcoma, the main malignant primary bone tumor, affects a ‘young’ population composed of children and young adults. Current treatment consists of tumor resection associated with chemotherapy. Unfortunately in many cases, a lack of response to anti-tumor drugs is observed, leading to development of metastases and to the patient’s death. Because TGF-β promotes metastases from many solid epithelial tumors, we investigated the effect of inhibitory Smad7 ov...

ba0001pp502 | Paediatric bone disease | ECTS2013

Craniofacial consequences of high-dose zoledronic acid injections in onco-pediatric patients

Lezot Frederic , Chesneau Julie , Battaglia Severine , Brion Regis , Farges Jean-Christophe , Lescaille Geraldine , Castaneda Beatriz , Marec-Berard Perrine , Brugieres Laurence , Corradini Nadege , Heymann Dominique , Redini Francoise

Background: High zoledronic acid (ZOL) dose protocol, one of the most potent inhibitors of bone resorption, is currently evaluated in a phase III clinical trial in Europe for the treatment of malignant pediatric primary bone tumors. The impact of such an intensive treatment on the craniofacial skeleton growth is a critical question in the context of patients with actively growing skeleton, in the light of our previous studies evidencing that endochondral bone formation was tra...

ba0002p122 | (1) | ICCBH2013

Fasting total ghrelin levels are increased in patients with adolescent idiopathic scoliosis

Gennero Isabelle , Conte-Auriol Francoise , Mus Marianne , Molinas-Cazals Catherine , Accadbled Franck , Tauber Maithe , De Gauzy Jerome Sales , Salles Jean Pierre

Objectives: Ghrelin is an orexigenic hormone produced by the stomach that reflects body weight changes and stimulates GH secretion. Recently, it has been shown to be associated with bone metabolism and eating behaviour. The underlying pathophysiology of adolescent idiopathic scoliosis (AIS) refers to possible abnormal bone development. AIS patients also frequently present with low BMI level.Eating behavioural disorders, endocrine disorders, abnormal grow...

ba0003pp375 | Other diseases of bone and mineral metabolism | ECTS2014

Osteoprotegerin and bone-like vascular calcification are predictive markers of vulnerable carotid plaques

Heymann Marie Francoise , Davaine Jean Michel , Laperine Olivier , Merlini Thierry , Guyomarch Beatrice , Chatelais Mathias , Guilbaud Florian , Brennan Meadhbh Aine , Heymann Dominique , Goueffic Yann

Vascular calcification has a marked impact on arterial heterogeneity and plaque stability. Based on a cohort of 116 patients (carotid and femoral endarterectomies), the aim of the present study was to determine the influence of the bone-like vascular calcification and of osteoprotegerin (OPG) on plaque stability.Seventy-three carotid and 43 femoral plaques along with plasma were harvested and analyzed in a single center study. The presence of osteoid met...